Liberty review

Liberty posts $116 for a one-month sermorelin supply and $149 for NAD⁺. Its compounded GLP-1 pages claim sourcing through FDA-registered 503B outsourcing facilities, but no facility is named, and Liberty does not say whether that source fills sermorelin or NAD⁺. The company also gives conflicting 47-state and 50-state claims without naming exclusions. Its policy contacts use a different domain from its footer. Confirm the dispensing facility and eligibility before paying.

Liberty (branded Liberty Health) sells compounded sermorelin and NAD⁺ injections, metformin, compounded semaglutide and tirzepatide injections, low-dose GLP-1 options and a sexual-health product called LibertyReady. A licensed provider reviews the online quiz before prescribing. It advertises free shipping, support, a free consultation and HSA/FSA use. Its GLP-1 product pages claim 503B outsourcing, without naming a facility or establishing the dispenser for the peptide products. Product pages say it is licensed in 47 states, while a statistics block claims 50; the exclusions and product-level eligibility are not listed.

The quiz leads to licensed clinician review, with no charge until prescribed. Liberty's GLP-1 pages claim 503B outsourcing: registered facilities must follow current good manufacturing practice requirements and are subject to FDA inspection. The specific facility is unnamed, and Liberty does not identify the source for sermorelin or NAD⁺. No legal operating company or medical director is named. The footer gives an Austin address and an 888 number, while refund and terms pages use another domain and a 555 phone number. The about page says Liberty offers only FDA-approved medications, contradicting its compounded-product disclosures. Its LegitScript badge links to a general homepage rather than a certification record. Product pages claim 47-state coverage and a statistics block claims 50, without naming exclusions.

Liberty shows its prices on each product page. Compounded sermorelin is $116 for a one-month supply or $296 for three months, which the page presents as $99 a month; NAD⁺ injections are $149 for one month or $380 for three, presented as $127 a month. At $116 for one month, it is a low sermorelin price. The three-month plans, selected by default on the product pages, are billed up front, and the refund policy says cancellations must be made at least three business days before the next shipment. The site does not always agree with itself: its FAQ quotes semaglutide from $199 and tirzepatide from $299 a month, while the product pages show compounded semaglutide at $129 a month ($329 for three months) and tirzepatide at $219 a month ($558 for three). Metformin is $49, which is a separate product and not a microdosing price. Verify any figure at checkout before paying.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Liberty's GLP-1 product pages claim FDA-registered 503B outsourcing, a category subject to CGMP and FDA inspection, but do not name the facility or establish whether that pathway fills sermorelin or NAD⁺. No compounded finished drug is FDA-approved. On the evidence: sermorelin is a GHRH analog that stimulates your own pituitary to release growth hormone rather than supplying it exogenously, so the somatostatin feedback loop is preserved. The mechanism is real and well described; the long-term human outcome data behind the body-composition, sleep and recovery claims stays thin. Injected NAD⁺ has no controlled human outcome trials at all — the single human intravenous study was a pharmacokinetic pilot finding infused NAD⁺ clears from plasma quickly — while the oral precursors NR and NMN reliably raise blood NAD⁺, a biomarker rather than a demonstrated clinical benefit. Individual results vary.